Anixa Biosciences Inc (ANIX)
Healthcare
Biotechnology
3.40 $
-3.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Anixa Biosciences Inc (ANIX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -7.2 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.4 | 1.4 | -3.4 | -3.8 | -4.3 | -4.7 | -6.2 | -4.9 | -6.5 | -6.2 | -7.3 | -7.2 | |
| 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.5 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | -0.1 | |
| 3.1 | 2.7 | 0.9 | 1.7 | 8.6 | 5.5 | 3.9 | 7.5 | 6.0 | 4.4 | 4.4 | 3.7 | |
| 5.7 | 2.7 | 0.9 | 0.2 | 6.3 | 4.0 | 4.1 | 7.9 | 6.7 | – | – | – | |
| -1.0 | -0.9 | -0.2 | 0.4 | 0.1 | 0.5 | -0.5 | 0.1 | 0.5 | -1.1 | 0.5 | 0.2 | |
| 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -2.5 | 0.0 | 1.5 | -2.7 | 1.5 | -0.5 | -0.3 | -3.9 | -11 | -5.6 | 4.3 | 4.9 | |
| 0.0 | 0.0 | – | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 0.0 | -0.4 | 0.0 | -0.5 | 2.5 | 5.7 | 9.4 | – | 0.5 | 0.0 | 0.0 | 0.0 | |
| 3.5 | -3.0 | -3.0 | -3.0 | – | – | – | – | – | – | – | – | |
| 7.3 | -0.4 | 0.0 | 7.4 | 2.5 | 5.7 | 9.4 | 32 | 0.5 | 0.4 | 3.4 | 2.3 | |
| 2.5 | 1.0 | -1.9 | 0.9 | -0.3 | 0.4 | 2.9 | 23 | -17 | -11 | 0.4 | 0.0 | |
| -2.4 | 1.3 | -3.5 | -3.8 | -4.3 | -4.9 | -6.2 | -4.9 | -6.5 | -6.2 | -7.3 | -7.2 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.